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Objectives
For the last 10 years there has been an epidemic of hepatitis C virus (HCV) infection in men
who have sex with men (MSM) in Europe, North America and Australia. The majority of those
infected are also HIV-positive and it is unclear to what extent HIV-negative MSM are also at
increased risk of infection with HCV. This study provides the first examination of the association
between HIV and hepatitis C serostatus in a sample of MSM recruited in community settings.
Methods
A total of 1121 participants completed a short questionnaire in 2008/2009 giving demographic
and behavioural data, and donated a sample of oral fluid that was subsequently tested for
antibodies to selected pathogens (HIV, syphilis and HCV).
Results
The seroprevalence of hepatitis C antibody was 2.1% [95% confidence interval (CI) 1.4–3.2%].
It was more common in those with HIV infection [7.7% (95% CI 4.2–12.9%) vs. 1.2% (95% CI
0.6–2.1%) in those without HIV infection; P < 0.001], those with a history of syphilis [12.2%
(95% CI 4.6–24.8%) vs. 1.7% (95% CI 1.0–2.6%) in those without such a history; P < 0.001] and
those who reported casual unprotected anal intercourse in the previous year [4.1% (95% CI
2.0–7.4%) vs. 1.2% (95% CI 0.5–2.2%) in those who did not report such intercourse; P = 0.01].
There was no relationship between hepatitis C antibody (anti-HCV) status and other demographic
variables (age, ethnicity, employment status or education).
Conclusions
The seroprevalence of anti-HCV in HIV-negative MSM (1.2%) was higher, but not significantly
higher, than that in the general population (0.67%). The prevalence was significantly higher in
those infected with HIV or with previous syphilis infection and in those reporting unprotected anal
intercourse. Our findings support current British Association for Sexual Health and HIV guidelines
recommending the provision of selective HCV testing in MSM according to individual risk profile.
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Introduction
In the UK, most cases of hepatitis C are contracted through
injecting drug use [1] but since around 2000 there has
also been an epidemic in HIV-positive men who have sex
with men (MSM) [2]. This epidemic initially appeared to be
restricted to Europe [3–5] but has since spread to North
America and Australia.
There is conflicting evidence of the degree to which
there has been spread to HIV-negative MSM [6–8]. Of the
first 105 cases reported by genitourinary medicine (GUM)
clinics between January 2008 and May 2009 to The
Enhanced Surveillance of Newly Acquired Hepatitis C
Infection in MSM (SNAHC), 96% were already diagnosed as
HIV positive [9].
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The latest estimate (for 2005) of the prevalence of anti-
hepatitis C virus (HCV) antibody (anti-HCV) in the general
population of England aged 15 to 59 years is 0.67% [10].
Studies in central London GUM clinics have found the
prevalence of anti-HCV among HIV-negative MSM to be
0.61–0.7% [7,8], while in HIV-positive MSM the prevalence
nationally is estimated to be 7.2% [11]. To our knowledge,
there has been no prior estimate of the community preva-
lence of HCV antibody in MSM.
Hepatitis C testing is not universal for HIV-negative
MSM attending GUM clinics. The British Association for
Sexual Health and HIV UK National Guideline on the
Management of the Viral Hepatitides A, B & C 2008 [12]
states that testing can be considered in MSM. This study
evaluates the current prevalence of hepatitis C antibody in
a community sample to determine whether this guideline
should be revised.
Methods
The Gay Men’s Sexual Health Survey was first carried out
in 1996 [13]. Its purpose is to investigate changes in the
sexual risk behaviour for HIV infection of MSM over time.
Participants are recruited from gay bars, clubs and saunas
across London as part of a repeat cross-sectional survey.
The survey consists of an anonymous self-completion
paper questionnaire including demographic and behav-
ioural questions. In 2008, an oral fluid sample was col-
lected and tested for antibodies to HIV, HCV and syphilis
and the results linked to the anonymous questionnaire.
Testing for the three markers was performed at the
Health Protection Agency (HPA), Colindale, London, using
the HIV 1+2 IgG antibody capture ELISA (GACELISA),
Ortho HCV enzyme-linked immunosorbent assay (ELISA)
(Ortho-Clinical Diagnostics Inc., Raritan, New Jersey, USA)
and Murex Syphilis immune-capture EIA tests (Diasorin,
Saluggia, Italy) [14–16]. HIV 1+2 GACELISA is an in-house
test; the HCV and syphilis tests are commercial tests
employing procedures developed, optimized and character-
ized at the HPA for oral fluid testing.
Associations with anti-HCV status were assessed using
Fisher’s exact test for categorical factors and the Mann–
Whitney test for ordinal factors.
Ethical approval for all aspects of the study was obtained
from UCL Ethics Committee.
Results
Questionnaires were received from 1279 MSM, 1121 of
whom also gave a sample of oral fluid using the OraSure™
(OraSure Technologies, Inc., Bethlehem, USA) collection
device. The median age was 33 years (range 16–81 years).
Most (83.8%) were of White ethnicity, 3.4% were Black,
1.9% were South-East Asian, 2.5% were Asian and 8.5%
were of other ethnicities.
The prevalence of antibodies to HCV was 2.1% [24 of
1121; 95% confidence interval (CI) 1.4–3.2%].
Anti-HCV was more common in the 168 subjects (15.0%)
who tested positive for HIV [7.7% (95% CI 4.2–12.9%) vs.
1.2% (95% CI 0.6–2.1%) in those who did not test positive;
P < 0.001] and in the 49 subjects (4.4%) who tested positive
for syphilis [12.2% (95% CI 4.6–24.8%) vs. 1.7% (95% CI
1.0–2.6%) in those who did not test positive; P < 0.001].
There was no statistically significant association between
anti-HCV and age (P = 0.24), ethnicity (P = 0.66), employ-
ment status (P = 0.76) or duration of education after age 16
years (P = 0.71).
Hepatitis C antibody was more common in those who had
attended a GUM clinic in the previous year (3.4% vs. 0.9% in
those who had not attended a GUM clinic; P < 0.01) and in
those who reported having a sexually transmitted infection
(STI) in the previous year (4.7% vs. 1.8% in those who did
not report an STI; P = 0.03) but not in those who had been
tested for HIV in the previous year (1.9% vs. 2.2% in those
who had not been tested for HIV; P = 0.83).
Hepatitis C seropositivity was not associated with
reported unprotected anal intercourse (UAI) in the last year
(2.9% vs. 1.4% for those who did not report UAI; P = 0.10)
but was associated with UAI with casual partners [4.1%
(95% CI 2.0–7.4%) vs. 1.2% (95% CI 0.5–2.2%) for those
who did not report UAI with casual partners; P = 0.01].
It was not associated with reported UAI with a partner
of a discordant or unknown HIV status in all partici-
pants (4.3% vs. 2.1% for no such reported UAI; P = 0.26)
or in HIV-negative MSM (2.0% vs. 1.5%, respectively;
P = 0.70).
HIV-negative MSM who attended a GUM clinic in the
previous year were no more likely to be anti-HCV positive
than those who did not attend (1.4% vs. 1.0%, respectively;
P = 0.76).
Discussion
We found the prevalence of anti-HCV in MSM overall to be
2.1%, which is significantly higher than the 0.67% estimate
for those of similar age in the general UK population.
Anti-HCV was nearly seven times more common in HIV-
positive than in HIV-negative MSM and the prevalence in
HIV-negative MSM (1.2%; 95% CI 0.58–2.1%) was not
significantly higher than in the general population.
Anti-HCV was also more common in those who tested
positive for syphilis or reported an STI in the previous year.
It was more common in those reporting UAI with casual
partners.
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The Gay Men’s Sexual Health Survey (2008) did not
ask participants about injecting drug use and so we were
unable to control for this major risk factor for hepatitis C.
In a community sample of MSM in London we did not
find any evidence of a large number of HIV-negative MSM
with evidence of exposure to hepatitis C. This supports the
practice at most GUM clinics where HCV testing (which
should be performed annually in those who are HIV posi-
tive and more frequently in those at increased risk of HCV
infection) is not routine for HIV-negative MSM. It also
suggests that the British Association for Sexual Health and
HIV guidelines should not change, and should continue
to recommend that HCV testing be considered for MSM,
according to risk profile. Those with a history of UAI with
casual partners and those with syphilis infection should be
considered at higher risk.
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